Abstract
The presumable relationship between viruses and malignant disease has been studied. Approximately 4000 assays for antibodies to adenovirus were carried out with sera of patients with malignant and nonmalignant diseases of the urogenital organs and other organic diseases. The search was directed in the first place at antibodies to the early non-virion antigens of adenovirus-12 of oncogenic properties. On the evidence of the complement fixation reaction antibodies to adenoviruses were found to be less frequent in malignant tumors and in hypertrophy of the prostate than in the control group. Antibody to the non-virion antigen of adenoviruses was found in 53 per cent of patients with neoplastic diseases and prostatic hypertrophy, in 18 per cent of those with urogenital diseases other than tumors and in 4 per cent of those with other organic diseases. The results point to a possible role of adenoviruses in tumors of the urogenital organs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Becker, F. F.: Cancer, Vol. 2. Etiology: Viral carcinogenesis. Plenum Press, New York 1975.
Centifanto, Y. M., Kaufman, H. E., Zam, Zs.: Herpesvirus particles in prostatic carcinoma cell.J. Virol., 2, 1608 (1973).
Dmochowski, L., Ohstuki, Y., Seman, G., Maruyama, K., Knesek, J. E., East, J. L., Bowen, J. M., Yoshida, H., Johnson, D. E.: Search for oncogenic viruses in human prostate cancer.Cancer Treatm. Rep., 61, 119 (1977).
Docherty, J. J., Chopan, M.: The latent herpes virus.Bact. Rev., 38, 337 (1974).
Elliott, A. Y., Fraley, E. E., Cleveland, P., Castro, A. E., Stein, N.: Isolation of RNA virus from papillary tumours of the human renal pelvis.Science, 179, 393 (1973).
Feldman, L. A., Rapp, F.: Inhibition of adenovirus replication by 1-B-D-arabino-furanosylcytosine.Proc. Soc. Exp. Biol. Med., 122, 243 (1966).
Garfinkle, B., McAuslan, B. R.: Transformation of cultured mammalian cells by viable herpes simplex virus subtypes 1 and 2.Proc. Nat. Acad. Sci. (USA), 71, 220 (1974).
Géder, L., Sanford, E. J., Rohner, T. J., Rapp, F.: Cytomegalovirus and cancer of the prostate: In vitro transformation of human cell.Cancer Treatm. Rep., 61, 139 (1977).
Gönchöl, É.: Study of the biological consequences of cytomegalovirus infection. Candidate's Thesis, Debrecen 1975.
Hollinshead, A. C., Lee, O. B., Chretien, P. B., Tarpley, J. L., Rawls, W. E., Adam, E.: Antibodies to herpesvirus non-virion antigens in squamous carcinoma.Science, 182, 713 (1973).
Kulcsár, G., Dömötöri, J., Dán, P., Nász, I., Keskeny, S., Geck, P.: Virological studies on gynaecological patients.Zbl. Bakt. I. Abt. Orig., 231, 389 (1975).
Lengyel, A., Nász, I.: The oncogenic properties of adenoviruses.Orvosképzés, 42, 11 (1967).
Masukawa, T., Garancis, J. C., Rytel, M. W., Mattingly, R. F.: Herpes genitalis virus isolation from human bladder urine.Acta Cytol., 16, 416 (1972).
McCoombs, R. M.: Role of oncornaviruses in carcinoma of the prostate.Cancer Treatm. Rep., 61, 131 (1977).
Melnick, J. L., Courtney, R. J., Powell, K. L., Schaffer, P. A., Benyesh-Melnick, M., Dressman, G. R., Anzai, T., Adam, E.: Studies on herpes simplex virus and cancer.Cancer Res., 36, 845 (1976).
Murphy, W. M.: Herpesvirus in bladder cancer.Acta Cytol., 20, 207 (1976).
Nász, I., Béládi, I., Lengyel, A.: The adenoviruses and their pathogenic role. Akadémiai Kiadó, Budapest 1967 (in Hungarian).
Nász, I., Kulcsár, G.: The cell-transforming effect of oncogenic viruses in vitro as a model for tumor research.Gyógyszerészet, 13, 241 (1969).
Nász, I., Berencsi, Gy.: The DNA-molecular biologic properties of the adenovirus and its oncogenic capacity.Orv. Hetil., 116, 1503 (1975).
Notter, M. F., Docherty, J. J., Mortel, R., Hollinshead A. C.: Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue. Five case studies.Gynecol. Oncol., 6, 574 (1978).
Pácsa, S.: Relationship between cancer of the uterine cervix and herpes virus. Candidate's Thesis, Pécs 1977.
Rotkin, I. D.: A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents.Cancer Res., 33, 1353 (1973).
Sprecher-Goldberger, S., Thiry, L., Lefebvre, N., Dekegel, D., De Halleux, F.: Complement-fixing antibodies to adenovirus—associated viruses, adenoviruses, cytomegaloviruses and herpes simplex viruses in patients with tumours and in control individuals.Amer. J. Epidemiol., 94, 351 (1971).
The, T. H., Klein, G., Langenhuysen, M. A. C.: Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.Clin. Exp. Immunol., 16, 1 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Csata, S., Kulcsár, G., Horváth, J. et al. Study of antibodies to adenoviruses in patients with tumors of the urogenital system. International Urology and Nephrology 14, 115–119 (1982). https://doi.org/10.1007/BF02082615
Issue Date:
DOI: https://doi.org/10.1007/BF02082615